J Korean Med Sci.  2009 Apr;24(2):248-255. 10.3346/jkms.2009.24.2.248.

Multi-institutional Comparison of Intensity Modulated Radiation Therapy (IMRT) Planning Strategies and Planning Results for Nasopharyngeal Cancer

Affiliations
  • 1Department of Radiation Oncology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
  • 2Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. hee.ro.park@samsung.com
  • 3Department of Radiation Oncology, College of Medicine, Chung-Ang University, Seoul, Korea.
  • 4Department of Radiation Oncology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea.
  • 5Department of Radiation Oncology, Dong-A University Medical Center, Busan, Korea.
  • 6Department of Radiation Oncology, Ewha Womans University Mokdong Hospital, Seoul, Korea.
  • 7Department of Radiation Oncology, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, Korea.

Abstract

The intensity-modulated radiation therapy (IMRT) planning strategies for nasopharyngeal cancer among Korean radiation oncology facilities were investigated. Five institutions with IMRT planning capacity using the same planning system were invited to participate in this study. The institutions were requested to produce the best plan possible for 2 cases that would deliver 70 Gy to the planning target volume of gross tumor (PTV1), 59.4 Gy to the PTV2, and 51.5 Gy to the PTV3 in which elective irradiation was required. The advised fractionation number was 33. The planning parameters, resultant dose distributions, and biological indices were compared. We found 2-3-fold variations in the volume of treatment targets. Similar degree of variation was found in the delineation of normal tissue. The physician-related factors in IMRT planning had more influence on the plan quality. The inhomogeneity index of PTV dose ranged from 4 to 49% in Case 1, and from 5 to 46% in Case 2. Variation in tumor control probabilities for the primary lesion and involved LNs was less marked. Normal tissue complication probabilities for parotid glands and skin showed marked variation. Results from this study suggest that greater efforts in providing training and continuing education in terms of IMRT planning parameters usually set by physician are necessary for the successful implementation of IMRT.

Keyword

Radiotherapy; Intensity-Modulated; Radiotherapy Planning Computer-Assisted; Quality Assurance; Nasopharyngeal Neoplasms

MeSH Terms

Female
Humans
Male
Middle Aged
Nasopharyngeal Neoplasms/*radiotherapy
Parotid Gland/radiation effects
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted/*methods
Radiotherapy, Intensity-Modulated/*methods
Relative Biological Effectiveness
Skin/radiation effects
Tumor Burden
Young Adult

Figure

  • Fig. 1 Variation in the delineation of GTV (A), PTV1 (B), PTV2 (C) among institutions. Color key: red, institution 1; green, institution 2; blue, institution 3; yellow, institution 4; magenta, institution 5. GTV, gross tumor volume; PTV, planning target volume.

  • Fig. 2 Variation in the parotid gland delineation among institutions. Color key: red, institution 1; green, institution 2; blue, institution 3; yellow, institution 4; magenta, institution 5.

  • Fig. 3 Types of delineated pseudo-targets.

  • Fig. 4 Variation of isodose distribution among participating institutions (Case 2).

  • Fig. 5 Variation of the dose volume histogram for planning target volumes among participating institutions (Case 2). Color key: red, institution 1; green, institution 2; blue, institution 3; yellow, institution 4; magenta, institution 5.


Reference

1. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys. 2001. 51:880–914.
2. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, Xia P, Xiao Y, Xing L, Yu CX. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003. 30:2089–2115.
Article
3. Lee SW, Back GM, Yi BY, Choi EK, Ahn SD, Shin SS, Kim JH, Kim SY, Lee BJ, Nam SY, Choi SH, Kim SB, Park JH, Lee KK, Park SH, Kim JH. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006. 65:152–160.
Article
4. Lee SW, Kim GE, Suh CO, Chu SS, Lee KK, Moon SR. Intensity modulation technique using the complementary boost-fields for ethmoid sinus cancer. Clin Oncol (R Coll Radiol). 2002. 14:241–249.
Article
5. Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002. 53:12–22.
Article
6. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003. 55:312–321.
Article
7. Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, Worden FP, Urba S, Lin A, Schipper MJ, Wolf GT. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004. 59:28–42.
Article
8. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006. 24:2618–2623.
Article
9. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, Chiu SK, Choi PH, Teo PM, Kwan WH, Chan AT. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007. 25:4873–4879.
Article
10. Huh SJ. Korean Society of Therapeutic Radiology and Oncology (KOSTRO). Current status of the infrastructure and characteristics of radiation oncology in Korea. Jpn J Clin Oncol. 2007. 37:623–627.
Article
11. Kim JY, Kim DY, Kim TH, Park SY, Lee SB, Shin KH, Pyo H, Kim JY, Cho KH. Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorectal Dis. 2007. 22:373–379.
Article
12. Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005. 63:683–689.
Article
13. Choi Y, Kim JK, Lee HS, Hur WJ, Hong YS, Park S, Ahn K, Cho H. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer. Radiother Oncol. 2006. 81:158–162.
Article
14. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 1995. 32:1227–1237.
Article
15. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989. 16:1623–1630.
16. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991. 21:123–135.
Article
17. Claus F, Mijnheer B, Rasch C, Bortfeld T, Fraass B, De Gersem W, Wirtz H, Hoinkis C, Cho BC, Kwong LW, Bae H, Muller K, De Neve W. Report of a study on IMRT planning strategies for ethmoid sinus cancer. Strahlenther Onkol. 2002. 178:572–576.
Article
18. Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, Kavadi V, Liengswangwong V, Gordon W, Raben A, Strasser J, Koprowski C, Frank S, Chronowski G, Ahamad A, Malyapa R, Zhang L, Dong L. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys. 2007. 68:1512–1521.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr